Mettler-Toledo Research and Development Expenses 2010-2024 | MTD

Mettler-Toledo research and development expenses for the twelve months ending September 30, 2024 were $0.186B, a 0.51% increase year-over-year.

  • Mettler-Toledo annual research and development expenses for 2023 were $0.185B, a 4.61% increase from 2022.
  • Mettler-Toledo annual research and development expenses for 2022 were $0.177B, a 4.33% increase from 2021.
  • Mettler-Toledo annual research and development expenses for 2021 were $0.17B, a 21.17% increase from 2020.

Mettler-Toledo Research and Development Expenses 2010-2024 | MTD

  • Mettler-Toledo annual research and development expenses for 2023 were $0.185B, a 4.61% increase from 2022.
  • Mettler-Toledo annual research and development expenses for 2022 were $0.177B, a 4.33% increase from 2021.
  • Mettler-Toledo annual research and development expenses for 2021 were $0.17B, a 21.17% increase from 2020.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$228.6B
Intuitive Surgical (ISRG)$203.7B
Alcon (ALC)$44.9B
Edwards Lifesciences (EW)$42.7B
IQVIA Holdings (IQV)$36.5B
IDEXX Laboratories (IDXX)$34.6B
DexCom (DXCM)$33.9B
Waters (WAT)$24.7B
STERIS (STE)$21.8B
SONOVA HOLDING (SONVY)$20.8B
Hologic (HOLX)$16.3B
Fresenius Medical Care AG KGaA (FMS)$14.6B
Globus Medical (GMED)$12.6B
Sysmex ADR (SSMXY)$12B
Penumbra (PEN)$10.2B
Masimo (MASI)$9.3B
Glaukos (GKOS)$8.6B
Teleflex (TFX)$8.4B
Integer Holdings (ITGR)$4.8B
Inari Medical (NARI)$4.7B
PROCEPT BioRobotics (PRCT)$3.8B
Veracyte (VCYT)$3.5B
LivaNova (LIVN)$2.7B
Nihon Kohden (NHNKY)$2.6B
Tandem Diabetes Care (TNDM)$2.4B
TransMedics (TMDX)$2.3B
Elekta AB (EKTAY)$2.3B
Integra LifeSciences Holdings (IART)$2B
Alphatec Holdings (ATEC)$1.7B
RxSight (RXST)$1.4B